Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2020

Nov 16, 2020

SELL
$73.18 - $82.95 $414,857 - $470,243
-5,669 Closed
0 $0
Q2 2020

Aug 14, 2020

BUY
$70.42 - $80.13 $126,756 - $144,234
1,800 Added 46.52%
5,669 $438,000
Q4 2019

Feb 14, 2020

SELL
$77.58 - $87.54 $65,943 - $74,409
-850 Reduced 18.01%
3,869 $352,000
Q3 2019

Nov 12, 2019

BUY
$76.08 - $82.93 $142,726 - $155,576
1,876 Added 65.99%
4,719 $397,000
Q2 2019

Aug 13, 2019

SELL
$69.84 - $81.59 $108,671 - $126,954
-1,556 Reduced 35.37%
2,843 $238,000
Q1 2019

May 15, 2019

SELL
$69.58 - $79.36 $2,922 - $3,333
-42 Reduced 0.95%
4,399 $366,000
Q4 2018

Feb 14, 2019

BUY
$65.24 - $75.71 $289,730 - $336,228
4,441 New
4,441 $339,000

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $261B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track London & Capital Asset Management LTD Portfolio

Follow London & Capital Asset Management LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of London & Capital Asset Management LTD, based on Form 13F filings with the SEC.

News

Stay updated on London & Capital Asset Management LTD with notifications on news.